Extreme telomere erosion in ATM-mutated and 11q-deleted CLL patients is independent of disease stage

Leukemia

Volumn 26, Issue 4, 2012, Pages 826-830

  Britt Compton, B ^a   Lin, T T ^a   Ahmed, G ^b   Weston, V ^b   Jones, R E ^a   Fegan, C ^a   Oscier, D G ^c   Stankovic, T ^b   Pepper, C ^a   Baird, D M ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; PROTEIN P53;

CANCER PATIENT; CANCER PROGNOSIS; CELL CYCLE CHECKPOINT; CHROMOSOME 17P; CHROMOSOME DELETION; CHRONIC LYMPHATIC LEUKEMIA; COHORT ANALYSIS; DNA DAMAGE CHECKPOINT; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TELOMERE; TUMOR SUPPRESSOR GENE; WILD TYPE;

EID: 84859634101     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2011.281     Document Type: Letter

References (8)

1. Messmer BT, Messmer D, Allen SL, Kolitz JE, Kudalkar P, Cesar D et al. In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells. J Clin Invest 2005; 115: 755-764. (Pubitemid 40322252)
2. Damle RN, Batliwalla FM, Ghiotto F, Valetto A, Albesiano E, Sison C et al. Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations. Blood 2004; 103: 375-382. (Pubitemid 38140062)
3. Roos G, Krober A, Grabowski P, Kienle D, Buhler A, Dohner H et al. Short telomeres are associated with genetic complexity, high risk genomic aberrations, and short survival in chronic lymphocytic leukemia. Blood 2008; 111: 2246-2252. (Pubitemid 351451432)
4. Rossi D, Lobetti Bodoni C, Genuardi E, Monitillo L, Drandi D, Cerri M et al. Telomere length is an independent predictor of survival, treatment requirement and Richter0s syndrome transformation in chronic lymphocytic leukemia. Leukemia 2009; 23: 1062-1072.
5. Lin TT, Letsolo BT, Jones RE, Rowson J, Pratt G, Hewamana S et al. Telomere dysfunction and fusion during the progression of chronic lymphocytic leukaemia: evidence for a telomere crisis. Blood 2010; 116: 1899-1907.
6. Brugat T, Nguyen-Khac F, Grelier A, Merle-Beral H, Delic J. Telomere dysfunction-induced foci arise with the onset of telomeric deletions and complex chromosomal aberrations in resistant chronic lymphocytic leukemia cells. Blood 2010; 116: 239-249.
7. Sabourin M, Zakian VA. ATM-like kinases and regulation of telomerase: lessons from yeast and mammals. Trends Cell Biol 2008; 18: 337-346.
8. Austen B, Skowronska A, Baker C, Powell JE, Gardiner A, Oscier D et al. Mutation status of the residual ATM allele is an important determinant of the cellular response to chemotherapy and survival in patients with chronic lymphocytic leukemia containing an 11q deletion. J Clin Oncol 2007; 25: 5448-5457. (Pubitemid 350232222)